This week President Trump signed an order fast-tracking the federal review of psychedelics for mental health disorders. Read the story below and find out how this order may have far-reaching scientific consequences. One of the psychedelics in the news lately has been ibogaine, a psychoactive substance derived from the African Tabernanthe iboga shrub, It has shown the ability to mitigate opioid withdrawal symptoms as well as diminish craving for a range of drugs. Find out more below, and become familiar with kratom, a drug that is in a "wild west" stage. Speaking of psychedelics, see the story about the history (both good and bad) of LSD in psychiatry. We also feature an article about how an alcohol study has suggested that relapse and recovery memories may be stored side-by-side in the human brain. Then find out why the recent Xanax recall may not affect your client's prescription. MUCH MORE BELOW!

In our Research section, we feature a paper which discusses social barriers to engagement in treatment for those newly released from correctional facilities. These barriers include economic instability, lack of housing, unemployment and transportation challenges. Then, a study finds that alcohol-related content in social media increases the risk of drinking and alcohol problems among young adults. Next, read about the relative effectiveness, safety and acceptability of different pharmacological and psychosocial treatments for cannabis use disorder. Finally, explore a study that suggests that the initial dose of methadone given to hospitalized opioid-dependent individuals has a major effect on patient retention.

HEADLINES

Trump signs order fast tracking review of psychedelics for mental health disorders

Trump’s order on psychedelics could have far-reaching science consequences

Ibogaine: A psychedelic solution to the opioid epidemic?

The secret history of LSD in psychiatry

A look at the ‘Wild West’ of synthetic kratom

Brain stores relapse and recovery memories side by side, alcohol study suggests

NEW PAPERS AND REPORTS

Impact of social determinants on opioid use disorder treatment engagement after release from jail: a case note content analysis (Addiction Science and Clinical Practice. April 22, 2026)

The Relationship Between Alcohol-Related Content on Social Media and Alcohol Outcomes in Young Adults: A Scoping Review (Alcohol Current Reviews. April 21, 2026)

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysis (Addiction. April 15, 2026)

Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder (JAMA Network. April 15, 2026)

Find more research here